FDA
approval
· 2017-06-16
FDA Approved: DIFLUNISAL — Original Application (Zydus Pharmaceuticals (USA) Inc.)
Summary
FDA approved a generic diflunisal product (DIFLUNISAL) under ANDA 203547 for Zydus Pharmaceuticals USA Inc. It is indicated for relief of mild to moderate pain …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for DIFLUNISAL (DIFLUNISAL)